Status:
UNKNOWN
The Effect of Hyperbaric Chamber Treatment on Patients With Diabetic Retinopathy
Lead Sponsor:
Assaf-Harofeh Medical Center
Conditions:
Does Hyperbaric Chaber Treatment Improve Diabetic Retinopathy
Eligibility:
All Genders
18+ years
Brief Summary
Diabetic retinopathy (DR) is a common complication of diabetes and is divided into non proliferative DR and proliferative DR. The damage is caused by either macular edema, macular ischemia that can be...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Patients between ages 18-90 with Diabetes type I or II and diabetic retinopathy who are scheduled for hyperbaric treatment for other indications than DR.
- Patients who signed an informed consent form and agree to undergo an ophthalmic physical examination, Fundus photography and OCT prior to hyperbaric treatment and oCT exam following every 10 treatments in hyperbaric chamber. Total number of hyperbaric treatments will be conducted according to the main indication for which they have been assigned this treatment.
Exclusion
- Patients with Carotid stenosis of more than 70%
- Anemia of \< 10mg/Dl
- Patients with chest X ray pathology which cannot be admitted to hyperbaric chamber treatment.
- Patients with claustrophobia or that cannot decompress properly.
- Patients with any malignant disease
- Patients with inability to sign informed consent
- Decompression treatment will last 90 minutes in 2 atmospheres pressure with 100% oxygen.
- \-
Key Trial Info
Start Date :
September 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2016
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT02235935
Start Date
September 1 2014
End Date
September 1 2016
Last Update
September 10 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assaf Harofe Medical Center
Ẕerifin, Israel